<DOC>
	<DOCNO>NCT02523144</DOCNO>
	<brief_summary>Sedation Techniques child undergo transthoracic echocardiography ( TTE ) .</brief_summary>
	<brief_title>Dexmedetomidine Children Having Transthoracic Echocardiography</brief_title>
	<detailed_description>The goal study determine significant difference quality sedation two standard sedation technique two dos dexmedetomidine child undergo ( TTE ) .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Chloral Hydrate</mesh_term>
	<criteria>Outpatients schedule receive sedation transthoracic echocardiography Subject must candidate type anesthetic dos dexmedetomidine Must 3 month 36 month age The subject history cardiac conduction system disease ( e.g . 1st 2nd degree AV block ) channelopathy ( e.g . long QT ) . The subject take digoxin , alphaadrenergic betaadrenergic agonist antagonist ( e.g. , clonidine , propranolol , albuterol ) , antiarrhythmic medication , vasodilator ( e.g . ACE inhibitor ) The subject receive dose sedative within 48 hour . The subject lifethreatening , medical condition ( American Society Anesthesiologists Physical Status 4 , 5 ) . The American Society Anesthesiologists ( ASA ) classification scale measure physical status healthy patient . For study , focus child define ASA I , II III mean healthy child ( ASA I ) , child systemic disease mild well control ( ASA II ) child systemic disease severe control ( ASA III ) . The subject allergic contraindication drug use study . The subject previously treat protocol . The subject severe coarctation aorta ( risk exaggerate vasoconstriction ) The subject Moyamoya disease ( risk recurrent stroke )</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Transthoracic echocardiography</keyword>
	<keyword>echo</keyword>
	<keyword>TTE</keyword>
</DOC>